Search Results

Displaying Results 7476-7500 of 7527 "'RARE'"

Oct 14, 2025, 12:57 ET RSAC Conference Opens Annual Innovation Sandbox and Launch Pad Contest Submissions

Hugh Thompson, who will return to host the contest in 2026. "Submitting companies get the rare opportunity to have their solution reviewed and adjudicated by a panel of industry leaders with a platform to showcase themselves to the cybersecurity

More news about: RSAC


Oct 14, 2025, 12:16 ET Calmére Estate Winery Sold in Landmark Napa Valley Transaction

A Rare Turnkey Estate in the Heart of Carneros Located at 2750 Las Amigas Road in the southern Napa hills, Calmére Estate Winery

More news about: NAREIG


Oct 14, 2025, 10:01 ET Medical Second Opinion Market Size to Reach USD 12.7 Billion by 2031 Amid Rising Misdiagnosis Prevention and Telemedicine Integration | By DataM Intelligence

structured second opinion programs. A regional initiative established partnerships with international medical institutions for rare disease consultations. Japan is expected to reach USD 1.2 billion by 2031, emerging as a leading

More news about: DataM Intelligence 4 Market Research LLP


Oct 14, 2025, 10:00 ET Marble Raises $15.5M Series A to Scale Access to Youth Mental Health Care

they've built a model where schools don't have to pay a dime—and still get high-quality, timely care for their students. That kind of access shouldn't be rare, and we backed Marble because they're making it possible at scale." As Marble expands nationwide, its platform is also building

More news about: Marble Health


Oct 14, 2025, 09:55 ET FRESHBREW ACQUIRES LARGEST LICENSED BRANDED COFFEE PORTFOLIO IN THE NATION FROM WHITE COFFEE CORPORATION

its capabilities and growing the business," said Al Ansari, CEO of FreshBrew Group. "Acquiring a respected, family-led company like this presented a rare opportunity to strengthen our position in the coffee industry. Now is the perfect time to join forces, as FreshBrew continues to grow with purpose.

More news about: FreshBrew


Oct 14, 2025, 09:00 ET Renowned AI Researcher Bolei Zhou Joins Coco Robotics to Lead the World's Largest Autonomous Delivery Fleet

robotics. "As a researcher, I've spent my academic career advancing the science of AI and robotics," said Zhou. "Coco offers something rare: one of the world's largest robot fleets. By harnessing it, we can build AI systems that don't just work in theory, but thrive in the complex, unpredictable

More news about: Coco Robotics


Oct 14, 2025, 09:00 ET Kayou Shows Up for the Superfans at New York Comic Con with Unforgettable Fan Moments

From sold-out signings to cosplay meetups, surprise giveaways, and rare card displays, Kayou's booth was a can't-miss destination on the show floor. Countless fans lined up daily beneath the yellow Kayou flag to get their

More news about: Kayou


Oct 14, 2025, 09:00 ET Grow Therapy Names New Leaders in Marketing, Data & Design to Power Next Chapter

high-quality and affordable mental health care accessible to everyone addresses one of the most pressing issues of our time," said Ball. "I believe we have a rare opportunity to build a widely recognized and beloved brand that breaks from what people expect of the category, moves people, and makes a meaningful

More news about: Grow Therapy


Oct 14, 2025, 09:00 ET Mounting Pressures Demand Faster Action on Leave Management Practices and Policy Modernization, According to NFP Research

employees experiencing menopause symptoms. "While some accommodations are gaining traction, comprehensive menopause support remains rare," said Trapenasso. "The costs of inaction are real. Unmanaged symptoms can create productivity loss, disengagement and erosion of performance. Employers

More news about: NFP Corp.


Oct 14, 2025, 09:00 ET Complete Genomics Highlights New Products, Partnerships, First DNBSEQ User Group Meeting at ASHG 2025

Genomics will host a DNBSEQ™ User Group Meeting to bring together researchers and customers to share best practices, explore applications across oncology, rare disease and population genomics, and hear updates from the company on product innovations. The meeting will take place on Tuesday, Oct. 14, 2025,

More news about: Complete Genomics


Oct 14, 2025, 08:53 ET Kēvens Earns Grammy Consideration for 'Call To Balance' in Album of the Year and Global Album of the Year Categories

Born in Miami's vibrant club scene and mentored by Cedella Marley Booker, mother of reggae legend Bob Marley, Kēvens' career reflects a rare synthesis of heritage and innovation. From his early days performing with the Marley family's Le Coup to sharing stages with icons like Steven Tyler,

More news about: Kēvens


Oct 14, 2025, 08:42 ET Step Inside the Entrepreneur Organization Experience

founders and owners are invited to experience the power of the Entrepreneurs' Organization (EO) for a day hosted by the EO Baltimore Chapter. This offers a rare opportunity to step inside a global community of entrepreneurs who learn and grow together. The 

More news about: Entrepreneurs' Organization Baltimore


Oct 14, 2025, 08:35 ET Locksley Appoints Former U.S. Airforce Major General & General Dynamics IT Executive to Advisory Board

/PRNewswire/ -- Locksley Resources (ASX: LKY; OTCQX: LKYRF), the company focused on critical minerals with their Mojave Project in California targeting rare earth elements (REEs) and antimony, today announced the appointment of Major General (Ret.) Peter J. Lambert to the company's Advisory Board. He brings

More news about: Locksley Resources


Oct 14, 2025, 08:34 ET 100% Women-Owned Happenstance Whiskey Introduces Limited-Release Single Barrel

(BTI) delivers classic baking spices on the nose and palate, with warm, embracing honey notes on the finish. "I hand-picked these rare barrels to expand our premium whiskey selection. I'm really excited about this new release and think it complements our current portfolio perfectly,"

More news about: Happenstance Whiskey


Oct 14, 2025, 08:18 ET BERA.ai and The CMO Podcast with Jim Stengel Launch The Brand Builder's Playbook: A New Podcast for CMOs Navigating the Future of Marketing

prove impact, align with CEOs and CFOs, and deliver both short-term ROI and long-term enterprise value. The Brand Builder's Playbook offers a rare, unfiltered glimpse into how those decisions are made. "Marketers are sort of deer in the headlights right now," said Jim Stengel.

More news about: BERA.ai


Oct 14, 2025, 08:00 ET Orsini Selected as Specialty Pharmacy Partner for Boehringer Ingelheim's JASCAYD® (nerandomilast)

care since 1987, Orsini is a leader in rare diseases and gene therapies. Orsini partners with biopharma innovators, healthcare providers and payors to support patients and their families in accessing revolutionary treatments for rare diseases. Through integrated rare disease pharmacy solutions including

More news about: Orsini


Oct 14, 2025, 08:00 ET Agentic Summit: A Convergence of Tokenization, AI, and Global Capital in the UAE

TRUF.NETWORK by Truflation, and Anton Golub (RWA Labs). Agentic. will give attendees unsurpassed and rare insight into how global capital flows are being reshaped. Attendance is open to all actively involved in tokenization, market infrastructure, digital

More news about: MANTRA Chain


Oct 14, 2025, 08:00 ET Agentic Summit: A Convergence of Tokenization, AI, and Global Capital in the UAE

TRUF.NETWORK by Truflation, and Anton Golub (RWA Labs). Agentic. will give attendees unsurpassed and rare insight into how global capital flows are being reshaped. Attendance is open to all actively involved in tokenization, market infrastructure,

More news about: MANTRA Chain


Oct 14, 2025, 07:30 ET Soligenix Updates United States Medical Advisory Board for Cutaneous T-Cell Lymphoma

Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today the update of its United States (U.S.) Medical Advisory Board (MAB) for cutaneous T-cell

More news about: Soligenix


Oct 14, 2025, 07:13 ET Brogidirsen (NS-089/NCNP-02) 3.5 Year Clinical Trial Data for the Treatment of Duchenne Muscular Dystrophy Presented at 2025 World Muscle Society Congress

PARAMUS, N.J., Oct. 14, 2025 /PRNewswire/ -- NS Pharma, Inc. (NS Pharma), a biopharmaceutical leader in rare disease and subsidiary of Nippon Shinyaku Co., Ltd. (Nippon Shinyaku), announced today that the National Center of Neurology and Psychiatry (NCNP, Kodaira

More news about: NS Pharma, Inc.


Oct 14, 2025, 07:10 ET Final analysis of open-label extension (OLE) study of FINTEPLA® (fenfluramine) in Lennox-Gastaut syndrome published in Epilepsy & Behavior

About Lennox-Gastaut syndrome (LGS) Lennox-Gastaut syndrome (LGS) is a rare, severe developmental and epileptic encephalopathy (DEE) characterized by the presence of tonic seizures and at least one additional seizure type and

More news about: UCB


Oct 14, 2025, 07:00 ET Mallinckrodt Recognizes First Hepatorenal Syndrome (HRS) Awareness Day

(CKD)).1,2 HRS is estimated to affect more than 60,000 Americans annually, approximately 0.01% of the U.S. population,3 making it a rare condition; and rates of HRS hospitalizations are increasing.4 "We're proud to support this moment for the HRS community

More news about: Mallinckrodt plc


Oct 14, 2025, 07:00 ET CHICAGO VENTURE SUMMIT FUTURE OF FOOD RETURNS WITH BOLD FOCUS ON INNOVATION & SUSTAINABILITY

shaping the future of food. With Chicagoland recognized as the #1 food manufacturing hub in the U.S., the sold-out Summit offers media and industry a rare look inside one of the world's most dynamic food and agtech ecosystems. To learn more, visit

More news about: World Business Chicago


Oct 14, 2025, 00:30 ET The Science of Good Health Introduces Curated Line of Supplements

Why Choose The Science of Good Health: Each product from The Science of Good Health reflects a rare balance of purity, potency, and purpose. The brand's formulations are built on years of clinical experience and grounded in scientific research.

More news about: The Science of Good Health


Oct 13, 2025, 16:11 ET Mullins McLeod Surges Into SC Governor's Race with $1.4 Million Raised in First Quarter; Most from His Own Commitment, Not Political Pockets

independence; it is a declaration that he will lead by example. In an era when public trust is at an all-time low, his approach signals a return to something rare in politics; principled leadership that puts the people first. "The people of this state are hungry for authenticity," McLeod

More news about: Mullins McLeod


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.